Florida · 2025 Regular Session · Bill
SB 522: Sickle Cell Care Management and Treatment Education
Did not advance Official data
- Introduced
- In committee
- Passed one chamber
- Passed both chambers
- Enacted
- Did not advance
Last official action: ·Record last updated:
Plain-language summary
SB 522 is a bill introduced in the Florida Senate on February 6, 2025. According to its official title, it concerns: Sickle Cell Care Management and Treatment Education. Primary sponsor: Darryl Rouson (Democratic). Most recent recorded action (June 16, 2025): Died in Health Policy.
Generated automatically from the official title, sponsor list, and status record only. It does not characterize the bill’s purpose or effects. How summaries are written
Official summary
Abstract published by the legislature (via Open States). Text as published by the legislature; reproduced verbatim.
Sickle Cell Care Management and Treatment Education; Requiring the applicable licensing boards for specified health care professions to require a 2-hour continuing education course on sickle cell disease care management as part of every second biennial licensure or certification renewal; authorizing the applicable boards to approve additional equivalent courses to satisfy the requirement; authorizing health care practitioners holding two or more licenses or certificates subject to the course requirement to show proof of completion of one course to satisfy the requirement for all such licenses or certificates, etc.
Sponsors
Sponsors by party (alphabetical): Democratic 1
| Name | Role | Party | Chamber | District |
|---|---|---|---|---|
| Darryl Rouson | Primary sponsor | Democratic | Senate | 16 |
“Support” is shown only as formal sponsorship recorded by the legislature. Roll-call votes are available on the official bill page.
Recent official actions
- Died in Health Policy
- Indefinitely postponed and withdrawn from consideration
- Introduced
- Referred to Health Policy; Appropriations Committee on Health and Human Services; Fiscal Policy
- Filed